524 related articles for article (PubMed ID: 17584283)
41. Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
Tsika C; Tsilimbaris MK; Makridaki M; Kontadakis G; Plainis S; Moschandreas J
Acta Ophthalmol; 2011 Nov; 89(7):e573-8. PubMed ID: 21672183
[TBL] [Abstract][Full Text] [Related]
42. Macular Pigment Reflectometry: Developing Clinical Protocols, Comparison with Heterochromatic Flicker Photometry and Individual Carotenoid Levels.
Davey PG; Rosen RB; Gierhart DL
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444721
[TBL] [Abstract][Full Text] [Related]
43. Macular pigment and the edge hypothesis of flicker photometry.
Bone RA; Landrum JT; Gibert JC
Vision Res; 2004 Dec; 44(26):3045-51. PubMed ID: 15474577
[TBL] [Abstract][Full Text] [Related]
44. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
[TBL] [Abstract][Full Text] [Related]
45. [Macular pigment and age-related macular degeneration. Clinical implications].
Haddad WM; Souied E; Coscas G; Soubrane G
Bull Soc Belge Ophtalmol; 2006; (301):15-22. PubMed ID: 17552428
[TBL] [Abstract][Full Text] [Related]
46. Spatial profile of macular pigment and its relationship to foveal architecture.
Nolan JM; Stringham JM; Beatty S; Snodderly DM
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2134-42. PubMed ID: 18436846
[TBL] [Abstract][Full Text] [Related]
47. Effects of a lutein supplement on the plasma lutein concentration and macular pigment in patients with central serous chorioretinopathy.
Sawa M; Gomi F; Hara C; Nishida K
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5238-44. PubMed ID: 25074771
[TBL] [Abstract][Full Text] [Related]
48. Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation.
Corvi F; Souied EH; Falfoul Y; Georges A; Jung C; Querques L; Querques G
Br J Ophthalmol; 2017 Jun; 101(6):770-773. PubMed ID: 27587715
[TBL] [Abstract][Full Text] [Related]
49. Lutein and zeaxanthin measured separately in the living human retina with fundus reflectometry.
van de Kraats J; Kanis MJ; Genders SW; van Norren D
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5568-73. PubMed ID: 18676627
[TBL] [Abstract][Full Text] [Related]
50. Age-related macular degeneration: Effects of a short-term intervention with an oleaginous kale extract--a pilot study.
Arnold C; Jentsch S; Dawczynski J; Böhm V
Nutrition; 2013; 29(11-12):1412-7. PubMed ID: 24103519
[TBL] [Abstract][Full Text] [Related]
51. The role of macular pigment assessment in clinical practice: a review.
Bartlett H; Howells O; Eperjesi F
Clin Exp Optom; 2010 Sep; 93(5):300-8. PubMed ID: 20629669
[TBL] [Abstract][Full Text] [Related]
52. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
[TBL] [Abstract][Full Text] [Related]
53. Effect of 1-year lutein supplementation on macular pigment optical density and visual function.
Sasamoto Y; Gomi F; Sawa M; Tsujikawa M; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1847-54. PubMed ID: 21850440
[TBL] [Abstract][Full Text] [Related]
54. Macular pigment and healthy vision.
Optometry; 2009 Oct; 80(10):592-8. PubMed ID: 20576249
[TBL] [Abstract][Full Text] [Related]
55. Lutein and zeaxanthin in the eyes, serum and diet of human subjects.
Bone RA; Landrum JT; Dixon Z; Chen Y; Llerena CM
Exp Eye Res; 2000 Sep; 71(3):239-45. PubMed ID: 10973733
[TBL] [Abstract][Full Text] [Related]
56. The effect of lutein- and zeaxanthin-rich foods v. supplements on macular pigment level and serological markers of endothelial activation, inflammation and oxidation: pilot studies in healthy volunteers.
Graydon R; Hogg RE; Chakravarthy U; Young IS; Woodside JV
Br J Nutr; 2012 Jul; 108(2):334-42. PubMed ID: 22313522
[TBL] [Abstract][Full Text] [Related]
57. Nutritional manipulation of primate retinas, III: Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys.
Johnson EJ; Neuringer M; Russell RM; Schalch W; Snodderly DM
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):692-702. PubMed ID: 15671301
[TBL] [Abstract][Full Text] [Related]
58. Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Muenster Aging and Retina Study (MARS).
Dietzel M; Zeimer M; Heimes B; Claes B; Pauleikhoff D; Hense HW
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3452-7. PubMed ID: 21296816
[TBL] [Abstract][Full Text] [Related]
59. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.
Degli Esposti S; Egan C; Bunce C; Moreland JD; Bird AC; Robson AG
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6568-75. PubMed ID: 22899764
[TBL] [Abstract][Full Text] [Related]
60. Measurement of macular pigment optical density using two different heterochromatic flicker photometers.
Loane E; Stack J; Beatty S; Nolan JM
Curr Eye Res; 2007 Jun; 32(6):555-64. PubMed ID: 17612971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
